The Quantellect read.As of Nov 19, 2026, 20 active firms cover Incyte Corporation: 9 rate it Buy or better, 11 sit at Neutral, and 0 rate it Sell or worse, a neutral consensus. Targets span $90.00 to $157.00, a moderate spread. The average target of $126.60 sits 7% above the current $117.84. The rating mix has stayed broadly stable, with Buy-side ratings easing from 10 to 9 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.72 next quarter toward $8.64 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS20 active firms
Neutral
Strong Buy00%
Buy945%
Neutral1155%
Sell00%
Strong Sell00%
Based on 20 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$126.60
+7.4% upside
Average target across 20 active firms as of Nov 19, 2026 vs $117.84 current
Highest Target$157.00
Average Target$126.60
Lowest Target$90.00
Detailed analyst forecasts for INCY
Showing 1–21 of 21 named analysts shown · 20 active firms in the rating projection
As of Nov 19, 2026, 9 of 20 active firms rate INCY a Buy (11 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
INCY EPS & revenue forecast
EPS · NEXT QUARTER
$1.72
Range $1.15 – $1.95 · 7 analysts · -5% YoY
Next period, 7 analysts expect Incyte Corporation to earn $1.72 a share (range $1.15 – $1.95), versus $1.81 a year earlier. Full-year consensus is $3.46, growing to $8.64 the year after.
REVENUE · NEXT QUARTER
$1.4B
Range $1.3B – $1.4B · 7 analysts · +7% YoY
Revenue is expected to reach $1.4B (range $1.3B – $1.4B), +7.0% year-over-year. Full-year consensus is $6.1B, rising to $6.3B next year.
Top analysts covering Incyte Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on INCY.
#1
Michael Schmidt
Guggenheim · Rank #4
Buy
$152.00+29.0% to target
Overall win rate
53%
+ Follow
#2
Jessica Fye
JP Morgan · Rank #100
Neutral
$123.00+4.4% to target
Overall win rate
54%
+ Follow
#3
Andrew Berens
Leerink Partners · Rank #162
Buy
$155.00+31.5% to target
Overall win rate
53%
+ Follow
#4
Mitchell Kapoor
HC Wainwright & Co. · Rank #305
Buy
$152.00+29.0% to target
Overall win rate
33%
+ Follow
#5
TA
Tazeen Ahmad
B of A Securities · Rank #411
Buy
$140.00+18.8% to target
Overall win rate
46%
+ Follow
INCY stock forecast FAQ
What is INCY's average 12-month price target?+
The 20 active firms with a live target average $126.60 for Incyte Corporation over the next 12 months, ranging from a $157.00 high to a $90.00 low, as of Nov 19, 2026.
Is INCY stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 20 active firms as of Nov 19, 2026, 9 rate it Buy or Strong Buy, 11 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for INCY?+
The Street-high target is $157.00 (Stifel), and the Street-low is $90.00 (Oppenheimer). The average of all 20 active-firm targets is $126.60.
How many active Wall Street firms cover INCY?+
20 active firms have a recognized rating on Incyte Corporation as of Nov 19, 2026, and 20 active firms carry a live 12-month price target.
Who is the most accurate analyst covering INCY?+
Among analysts who currently cover INCY, Michael Schmidt of Guggenheim has the strongest overall Quantellect track record (Rank #4). Their current call is Buy with a $152.00 target.
What is Incyte Corporation's projected EPS for next quarter?+
The consensus estimate is $1.72 per share (range $1.15 – $1.95) across 7 analysts. Full-year EPS is projected at $3.46, rising to $8.64 the following year.
How much revenue is Incyte Corporation expected to report next quarter?+
Consensus revenue is $1.4B (range $1.3B – $1.4B). Full-year revenue is projected at $6.1B, growing to $6.3B next year.
Have analysts been upgrading or downgrading INCY lately?+
As of Nov 19, 2026, 9 of 20 active firms rate INCY a Buy (11 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their INCY calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.